Heart Test Laboratories, Inc. (HSCS) Tops Q2 EPS by 136c

Heart Test Laboratories, Inc. (NASDAQ: HSCS) reported Q2 EPS of ($2.64), $1.36 better than the analyst estimate of ($4.00).

For earnings history and earnings-related data on Heart Test Laboratories, Inc. (HSCS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Alphabet (GOOGL) Reiterated at Market Outperform by Citizens on YouTube's Scale, Distribution
• JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight